Cargando…
Human IL-6R(hi)TIGIT(−) CD4(+) CD127(low)CD25(+) T cells display potent in vitro suppressive capacity and a distinct Th17 profile
To date many clinical studies aim to increase the number and/or fitness of CD4(+) CD127(low)CD25(+) regulatory T cells (Tregs) in vivo to harness their regulatory potential in the context of treating autoimmune disease. Here, we sought to define the phenotype and function of Tregs expressing the hig...
Autores principales: | Ferreira, Ricardo C., Rainbow, Daniel B., Rubio García, Arcadio, Pekalski, Marcin L., Porter, Linsey, Oliveira, João J., Waldron-Lynch, Frank, Wicker, Linda S., Todd, John A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471606/ https://www.ncbi.nlm.nih.gov/pubmed/28284938 http://dx.doi.org/10.1016/j.clim.2017.03.002 |
Ejemplares similares
-
CD4(+)CD25(+)CD127(hi) cell frequency predicts disease progression in type 1 diabetes
por: Narsale, Aditi, et al.
Publicado: (2021) -
Peripheral CD4(+)CD25(hi)CD127(low) regulatory T cells are increased in patients with gastrointestinal cancer
por: Qiu, Junlan, et al.
Publicado: (2023) -
In-depth immunophenotyping data of IL-6R on the human peripheral regulatory T cell (Treg) compartment
por: Ferreira, Ricardo C., et al.
Publicado: (2017) -
CD4(+)CD25(hi)CD127(low) Regulatory T Cells Are Increased in Oral Squamous Cell Carcinoma Patients
por: Lim, Kue Peng, et al.
Publicado: (2014) -
CD56(bright) natural killer cells preferentially kill proliferating CD4(+) T cells
por: Lee, Mercede, et al.
Publicado: (2023)